1 Market Overview
1.1 Natural Killer Cell Therapies Introduction
1.2 Market Analysis by Type
1.2.1 NK Cell Therapies
1.2.2 NK Cell Directed Antibodies
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Gastrointestinal Diseases
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Nektar Therapeutics
2.1.1 Business Overview
2.1.2 Natural Killer Cell Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Kiadis Pharma
2.2.1 Business Overview
2.2.2 Natural Killer Cell Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Chipscreen Biosciences
2.3.1 Business Overview
2.3.2 Natural Killer Cell Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Innate
2.4.1 Business Overview
2.4.2 Natural Killer Cell Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Innate Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Dragonfly Therapeutics
2.5.1 Business Overview
2.5.2 Natural Killer Cell Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Affimed
2.6.1 Business Overview
2.6.2 Natural Killer Cell Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Affimed Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Nkarta Therapeutics
2.7.1 Business Overview
2.7.2 Natural Killer Cell Therapies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Glycostem
2.8.1 Business Overview
2.8.2 Natural Killer Cell Therapies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Glycostem Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Fate Therapeutics
2.9.1 Business Overview
2.9.2 Natural Killer Cell Therapies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 NantWorks
2.10.1 Business Overview
2.10.2 Natural Killer Cell Therapies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 NantWorks Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 Fortress Biotech
2.11.1 Business Overview
2.11.2 Natural Killer Cell Therapies Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Natural Killer Cell Therapies Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Natural Killer Cell Therapies Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Natural Killer Cell Therapies Manufacturer Market Share in 2019
3.3.2 Top 6 Natural Killer Cell Therapies Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Natural Killer Cell Therapies Market Analysis by Regions
4.1 Global Natural Killer Cell Therapies Sales, Revenue and Market Share by Regions
4.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Regions (2015-2019)
4.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Regions (2015-2019)
4.2 North America Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
4.3 Europe Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
4.5 South America Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
5 North America Natural Killer Cell Therapies by Country
5.1 North America Natural Killer Cell Therapies Sales, Revenue and Market Share by Country
5.1.1 North America Natural Killer Cell Therapies Sales and Market Share by Country (2015-2019)
5.1.2 North America Natural Killer Cell Therapies Revenue and Market Share by Country (2015-2019)
5.2 United States Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
5.3 Canada Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
5.4 Mexico Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
6 Europe Natural Killer Cell Therapies by Country
6.1 Europe Natural Killer Cell Therapies Sales, Revenue and Market Share by Country
6.1.1 Europe Natural Killer Cell Therapies Sales and Market Share by Country (2015-2019)
6.1.2 Europe Natural Killer Cell Therapies Revenue and Market Share by Country (2015-2019)
6.2 Germany Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
6.3 UK Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
6.4 France Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
6.5 Russia Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
6.6 Italy Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
7 Asia-Pacific Natural Killer Cell Therapies by Country
7.1 Asia-Pacific Natural Killer Cell Therapies Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Natural Killer Cell Therapies Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Natural Killer Cell Therapies Revenue and Market Share by Country (2015-2019)
7.2 China Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
7.3 Japan Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
7.4 Korea Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
7.5 India Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
8 South America Natural Killer Cell Therapies by Country
8.1 South America Natural Killer Cell Therapies Sales, Revenue and Market Share by Country
8.1.1 South America Natural Killer Cell Therapies Sales and Market Share by Country (2015-2019)
8.1.2 South America Natural Killer Cell Therapies Revenue and Market Share by Country (2015-2019)
8.2 Brazil Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
8.3 Argentina Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
8.4 Colombia Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
9 Middle East and Africa Natural Killer Cell Therapies by Countries
9.1 Middle East and Africa Natural Killer Cell Therapies Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Natural Killer Cell Therapies Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Natural Killer Cell Therapies Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
9.3 Turkey Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
9.4 Egypt Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
9.5 Nigeria Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
9.6 South Africa Natural Killer Cell Therapies Sales and Growth Rate (2015-2019)
10 Global Natural Killer Cell Therapies Market Segment by Type
10.1 Global Natural Killer Cell Therapies Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Type (2015-2019)
10.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Type (2015-2019)
10.2 NK Cell Therapies Sales Growth and Price
10.2.1 Global NK Cell Therapies Sales Growth (2015-2019)
10.2.2 Global NK Cell Therapies Price (2015-2019)
10.3 NK Cell Directed Antibodies Sales Growth and Price
10.3.1 Global NK Cell Directed Antibodies Sales Growth (2015-2019)
10.3.2 Global NK Cell Directed Antibodies Price (2015-2019)
11 Global Natural Killer Cell Therapies Market Segment by Application
11.1 Global Natural Killer Cell Therapies Sales Market Share by Application (2015-2019)
11.2 Cancer Sales Growth (2015-2019)
11.3 Gastrointestinal Diseases Sales Growth (2015-2019)
11.4 Others Sales Growth (2015-2019)
12 Natural Killer Cell Therapies Market Forecast (2020-2025)
12.1 Global Natural Killer Cell Therapies Sales, Revenue and Growth Rate (2020-2025)
12.2 Natural Killer Cell Therapies Market Forecast by Regions (2020-2025)
12.2.1 North America Natural Killer Cell Therapies Market Forecast (2020-2025)
12.2.2 Europe Natural Killer Cell Therapies Market Forecast (2020-2025)
12.2.3 Asia-Pacific Natural Killer Cell Therapies Market Forecast (2020-2025)
12.2.4 South America Natural Killer Cell Therapies Market Forecast (2020-2025)
12.2.5 Middle East and Africa Natural Killer Cell Therapies Market Forecast (2020-2025)
12.3 Natural Killer Cell Therapies Market Forecast by Type (2020-2025)
12.3.1 Global Natural Killer Cell Therapies Sales Forecast by Type (2020-2025)
12.3.2 Global Natural Killer Cell Therapies Market Share Forecast by Type (2020-2025)
12.4 Natural Killer Cell Therapies Market Forecast by Application (2020-2025)
12.4.1 Global Natural Killer Cell Therapies Sales Forecast by Application (2020-2025)
12.4.2 Global Natural Killer Cell Therapies Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
